What should you know about secondary antibody immunohistochemistry?

A tissue section is prepared on a slide. A primary antibody is selected to recognise a particular protein or marker in the cells. A secondary antibody then attaches to the primary antibody and carries an enzyme or fluorescent label. The label produces a coloured or illuminated signal that can be examined under a microscope.

The secondary antibody does not identify cancer by itself. The laboratory interprets the signal’s location, pattern and strength alongside the tissue appearance, clinical information and other tests. Controls help show whether staining behaved as expected. Different antibody systems and markers answer different diagnostic questions.

Ask which marker was tested, what the staining pattern showed and whether the result is considered positive, negative, weak or equivocal in that context. Ask whether the sample contained enough representative tissue and whether another stain, molecular test or pathology review is needed.

Keep the pathology report with your other medical records. If the result is being used to guide treatment, ask how it fits with the biopsy findings, scan results and overall diagnosis. A pathologist may review the slides when the interpretation is uncertain or the diagnosis is complex.

The laboratory technique itself usually does not create symptoms because it is performed on collected tissue. Contact your care team promptly if the biopsy site develops increasing pain, bleeding, redness, swelling, discharge or fever. Ask about a delayed report when the result is needed for a treatment decision.

What marker was tested and why? What did the staining pattern mean for my diagnosis? Was a secondary antibody system used, and were the controls acceptable? Does this result affect treatment choices? Would another stain, test or pathology review clarify the finding?